Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel therapeutic strategies for cardioprotection.
Sluijter JP, Condorelli G, Davidson SM, Engel FB, Ferdinandy P, Hausenloy DJ, Lecour S, Madonna R, Ovize M, Ruiz-Meana M, Schulz R, Van Laake LW; Nucleus of the European Society of Cardiology Working Group Cellular Biology of the Heart. Sluijter JP, et al. Among authors: ovize m. Pharmacol Ther. 2014 Oct;144(1):60-70. doi: 10.1016/j.pharmthera.2014.05.005. Epub 2014 May 13. Pharmacol Ther. 2014. PMID: 24837132 Review.
Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.
Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, Heusch G, Vinten-Johansen J, Yellon DM, Schulz R; Working Group of Cellular Biology of Heart of European Society of Cardiology. Ovize M, et al. Cardiovasc Res. 2010 Aug 1;87(3):406-23. doi: 10.1093/cvr/cvq129. Epub 2010 May 6. Cardiovasc Res. 2010. PMID: 20448097 Review.
Postconditioning in acute myocardial infarction patients.
Ivanes F, Rioufol G, Piot C, Ovize M. Ivanes F, et al. Among authors: ovize m. Antioxid Redox Signal. 2011 Mar 1;14(5):811-20. doi: 10.1089/ars.2010.3354. Epub 2010 Oct 6. Antioxid Redox Signal. 2011. PMID: 20578963 Review.
Cardioprotection in the clinical setting.
Ivanes F, Mewton N, Rioufol G, Piot C, Elbaz M, Revel D, Croisille P, Ovize M. Ivanes F, et al. Among authors: ovize m. Cardiovasc Drugs Ther. 2010 Jun;24(3):281-7. doi: 10.1007/s10557-010-6243-y. Cardiovasc Drugs Ther. 2010. PMID: 20589423 Review.
Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations.
Hausenloy DJ, Baxter G, Bell R, Bøtker HE, Davidson SM, Downey J, Heusch G, Kitakaze M, Lecour S, Mentzer R, Mocanu MM, Ovize M, Schulz R, Shannon R, Walker M, Walkinshaw G, Yellon DM. Hausenloy DJ, et al. Among authors: ovize m. Basic Res Cardiol. 2010 Nov;105(6):677-86. doi: 10.1007/s00395-010-0121-4. Epub 2010 Sep 24. Basic Res Cardiol. 2010. PMID: 20865418 Free PMC article.
Postconditioning: from the bench to bedside.
Cour M, Gomez L, Mewton N, Ovize M, Argaud L. Cour M, et al. Among authors: ovize m. J Cardiovasc Pharmacol Ther. 2011 Jun;16(2):117-30. doi: 10.1177/1074248410383174. Epub 2010 Oct 11. J Cardiovasc Pharmacol Ther. 2011. PMID: 20938041 Review.
Infarct size reduction in patients with STEMI: why we can do it!
Mewton N, Elbaz M, Piot C, Ovize M. Mewton N, et al. Among authors: ovize m. J Cardiovasc Pharmacol Ther. 2011 Sep-Dec;16(3-4):298-303. doi: 10.1177/1074248411412379. J Cardiovasc Pharmacol Ther. 2011. PMID: 21821532 Review.
298 results